NASDAQ · Diagnostics & Research
Illumina Inc (ILMN)
$192.82
-3.90%
36
In band
Moving averages
SMA 200$178.63+7.94%
Company profile
Illumina, Inc. is an American company. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets. Its headquarters are located in San Diego, California.
SectorHealthcare
IndustryDiagnostics & Research
Market cap$32.20B
P/E ratio36.65
EPS$5.81
Beta1.451
Dividend yield0.00%
52-week high$309.35
52-week low$112.65
Similar stocks in Diagnostics & Research
RSI alerts for ILMN
An email when ILMN closes below RSI 30 or above 70. Nothing else.
Data last updated 12 November 2026 at 11:45 PM EST